Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation

Recruiting Observational Study
Atrial Fibrillation Inflammation Genetic Predisposition to Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
182 (estimated)
Sponsor
Vrinnevi Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Because of the high recurrence rates following electrical cardioversion and high morbidity in AF patients there is a need to explore prediction models for AF recurrence following ECV. Previous studies have primarily focused on high-sensitivity CRP (hsCRP), CRP, and IL-6, while other inflammatory indexes and gene scores might hold greater value. This prospective cohort study is planning to include…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Persistent atrial fibrillation (ICD-10 I48.1) * Age over 18 years Exclusion Criteria: * Autoimmune disease * Inflammatory diseases * Acute or chronic liver dysfunction * Ongoing infectious diseases * Thyroid disorders * Any other conditions known to impact inflammatory activ…
Contacts

Jakob Hytting, MD

+46 + 707679724

jakob.hytting@liu.se

CONTACT